FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Allergic Asthma

  Link Details for: FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Allergic Asthma

Link Title:	FDA Approves Omalizumab (Xolair), a Recombinant Anti-IgE Antibody, to Treat Allergic Rhinitis and Allergic Asthma
Link URL:	http://www.aaaai.org/members/hottopic/omalizumab/professional.stm
Link Details:	June 2003 article on the drug's US approval. Includes information about results of clinical trials.
Category:	Top : Health : Pharmacy : Drugs_and_Medications : O : Omalizumab
Link Type:
ScreenShot: